North Carolina State University is the first university to offer peripheral blood stem cell transplantation for treatment of canine lymphoma. This treatment has been available to human lymphoma patients for many years. Although the therapy was developed using dogs, it has never been a standard treatment for canine lymphoma until now.
Currently, this is the only cure for canine lymphoma, with a success rate of at least 30%.
The conventional treatment for canine lymphoma is chemotherapy, with 12-18 months remission being the best outcome.
Some types of cancer respond well to a combination of conventional therapy and immune modulation therapy.